$0.80 -0.02 (-2.44%)
2/10/2012 4:00 PM

DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners


Advertisement